Literature DB >> 17336591

Neutrophil recruitment and barrier impairment in celiac disease: a genomic study.

Begoña Diosdado1, Harm van Bakel, Eric Strengman, Lude Franke, Erica van Oort, Chris J Mulder, Cisca Wijmenga, Martin C Wapenaar.   

Abstract

BACKGROUND & AIMS: Celiac disease is an enteropathy featuring villous atrophy, crypt hyperplasia, and lymphocytosis. Tissue remodeling is driven by an inflammatory reaction to gluten in genetically susceptible individuals. The adaptive pathway is considered the major immune response but recent evidence has indicated the involvement of innate immunity as well. To assess the contribution of either immune response we performed global gene expression profiling of the regenerating mucosa.
METHODS: Microarray hybridizations were performed with biopsy samples from 13 untreated patients, 31 patients on a gluten-free diet in various stages of remission, and 21 controls. Additional data were generated using low-density array and conventional quantitative reverse-transcription polymerase chain reaction, and immunohistochemistry.
RESULTS: A total of 108 differentially expressed immune-related genes were identified (50 innate, 43 adaptive, 9 both innate/adaptive, and 6 immunoregulatory). Expression levels showed a gradual change as opposed to the discrete histological transitions. In addition to details provided on the adaptive and innate immune pathways used, we observed a chronic recruitment of activated neutrophils. Neutrophil involvement was unabated in otherwise completely normalized remission patients.
CONCLUSIONS: We observed a contribution of both the innate and adaptive immune response in celiac disease pathogenesis. The discrepancy between the histological classification and the observed incremental change in immune-gene expression may have consequences for current diagnostic inclusion criteria. Enhanced neutrophil infiltration in both active and remission patients points to a genetic impairment of the intestinal barrier that may contribute to the cause rather than the consequence of celiac disease.

Entities:  

Mesh:

Year:  2007        PMID: 17336591     DOI: 10.1016/j.cgh.2006.11.014

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  17 in total

1.  Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease.

Authors:  Karen M Lammers; Sunaina Khandelwal; Fatima Chaudhry; Debby Kryszak; Elaine L Puppa; Vincenzo Casolaro; Alessio Fasano
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

Review 3.  Diagnosing celiac disease: A critical overview.

Authors:  Arzu Ensari; Michael N Marsh
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 4.  Osteoporosis in celiac disease and in endocrine and reproductive disorders.

Authors:  Anna-Velia Stazi; Antonello Trecca; Biagino Trinti
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

5.  Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice.

Authors:  T L Freitag; S Rietdijk; Y Junker; Y Popov; A K Bhan; C P Kelly; C Terhorst; D Schuppan
Journal:  Gut       Date:  2009-08-10       Impact factor: 23.059

6.  Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge.

Authors:  Ann-Christin Røberg Beitnes; Melinda Ráki; Margit Brottveit; Knut Erik Aslaksen Lundin; Frode Lars Jahnsen; Ludvig Magne Sollid
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

7.  Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1.

Authors:  Karen M Lammers; Marcello Chieppa; Lunhua Liu; Song Liu; Tatsushi Omatsu; Mirkka Janka-Junttila; Vincenzo Casolaro; Hans-Christian Reinecker; Carole A Parent; Alessio Fasano
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

8.  Potential blood-based markers of celiac disease.

Authors:  Hanna Bragde; Ulf Jansson; Mats Fredrikson; Ewa Grodzinsky; Jan Söderman
Journal:  BMC Gastroenterol       Date:  2014-10-09       Impact factor: 3.067

9.  Transcriptome-based identification of new anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions [corrected].

Authors:  Marika Massaro; Rosanna Martinelli; Valentina Gatta; Egeria Scoditti; Mariangela Pellegrino; Maria Annunziata Carluccio; Nadia Calabriso; Tonia Buonomo; Liborio Stuppia; Carlo Storelli; Raffaele De Caterina
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 10.  From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases.

Authors:  Vinod Kumar; Cisca Wijmenga; Sebo Withoff
Journal:  Semin Immunopathol       Date:  2012-05-14       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.